Dihydroartemisinin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial.

When the day 28 PCR-corrected cure rates were analysed by country, the heterogeneity test was borderline significant at the 10% level only in the ePP population (ITT: p = 0.324; ePP: p = 0.082), suggesting some minor differences among sites ( Figure 2 ).

also in 11,409 other papers